Lv5
930 积分 2022-10-11 加入
Design, synthesis and anti-necroptosis activity of fused heterocyclic MLKL inhibitors
1天前
已完结
Design, synthesis and anti-necroptosis activity of fused heterocyclic MLKL inhibitors
11天前
已完结
ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis
15天前
已完结
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
19天前
已完结
Protein shapeshifting in necroptotic cell death signaling
22天前
已完结
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
22天前
已完结
Discovery of novel biaryl benzoxazepinones as dual-mode receptor-interacting protein kinase-1 (RIPK1) inhibitors
22天前
已完结
N-(7-Cyano-6-(4-fluoro-3-(2-(3-(trifluoromethyl)phenyl)acetamido)phenoxy)benzo[d]thiazol-2-yl)cyclopropanecarboxamide (TAK-632) Analogues as Novel Necroptosis Inhibitors by Targeting Receptor-Interacting Protein Kinase 3 (RIPK3): Synthesis, Structure–Activity Relationships, and in Vivo Efficacy
1个月前
已完结
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
1个月前
已完结
Profiling of the chemical space on the phenyl group of substituted benzothiazole RIPK3 inhibitors
1个月前
已完结
皖公网安备34019202002308
